Personalized treatment of hepatitis B

by Anna S. Lok
Published 2015-03-01

SARS-CoV-2 vaccines: a triumph of science and collaboration

by Jonathan L. Golob, Njira Lugogo, Adam S. Lauring, Anna S. Lok
Published 2021-05-01

Patient disease knowledge, attitudes and behaviours related to non-alcoholic fatty liver disease: a qualitative study

by Anna S Lok, Monica A Tincopa, Jane Wong, Michael Fetters
Published 2021-09-01

Patient Education Improves Patient Knowledge and Acceptance on Antiviral Therapy of Hepatitis C in Rural China

by Ming Yang, Hui-Ying Rao, Bo Feng, Elizabeth Wu, Lai Wei, Anna S Lok
Published 2017-01-01

Incidence of and Risk Factors for Hepatic Encephalopathy in a Population‐Based Cohort of Americans With Cirrhosis

by Elliot B. Tapper, James B. Henderson, Neehar D. Parikh, George N. Ioannou, Anna S. Lok
Published 2019-11-01

Fat Accumulation, Liver Fibrosis, and Metabolic Abnormalities in Chinese Patients With Moderate/Severe Versus Mild Hepatic Steatosis

by Wei Zhang, Rui Huang, Yi Wang, Huiying Rao, Lai Wei, Grace L. Su, Anna S. Lok
Published 2019-12-01

Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C

by Huiying Rao, Huixin Liu, Elizabeth Wu, Ming Yang, Bo Feng, Andy Lin, Ran Fei, Robert J. Fontana, Lai Wei, Anna S. Lok
Published 2020-08-01

Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America

by Mayur Brahmania, Stephen Liu, Abdus S. Wahed, Colina Yim, Bettina E. Hansen, Mandana Khalili, Norah A. Terrault, Anna S. Lok, Marc Ghany, Junyao Wang, David Wong, Harry L.A. Janssen
Published 2020-07-01

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B

by Anna S. Lok, Fabien Zoulim, Geoffrey Dusheiko, Henry L.Y. Chan, Maria Buti, Marc G. Ghany, Anuj Gaggar, Jenny C. Yang, George Wu, John F. Flaherty, G. Mani Subramanian, Stephen Locarnini, Patrick Marcellin
Published 2020-01-01

An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.

by Thomas R O'Brien, James E Everhart, Timothy R Morgan, Anna S Lok, Raymond T Chung, Yongwu Shao, Mitchell L Shiffman, Myhanh Dotrang, John J Sninsky, Herbert L Bonkovsky, Ruth M Pfeiffer, HALT-C Trial Group
Published 2011-01-01

Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study

by A. Sidney Barritt, Stephanie Watkins, Norman Gitlin, Samuel Klein, Anna S. Lok, Rohit Loomba, Cheryl Schoen, K. Rajender Reddy, Huy Ngoc Trinh, Andrea R. Mospan, Miriam B. Vos, L. Michael Weiss, Kenneth Cusi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal
Published 2021-06-01

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic h...

by Donna M Evon, Paul W Stewart, Jipcy Amador, Marina Serper, Anna S Lok, Richard K Sterling, Souvik Sarkar, Carol E Golin, Bryce B Reeve, David R Nelson, Nancy Reau, Joseph K Lim, K Rajender Reddy, Adrian M Di Bisceglie, Michael W Fried
Published 2018-01-01

Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver

by Daniel Traum, Yue J. Wang, Kathleen B. Schwarz, Jonathan Schug, David K.H. Wong, Harry L.A. Janssen, Norah A. Terrault, Mandana Khalili, Abdus S. Wahed, Karen F. Murray, Phillip Rosenthal, Simon C. Ling, Norberto Rodriguez-Baez, Richard K. Sterling, Daryl T.Y. Lau, Timothy M. Block, Michael D. Feldman, Elizabeth E. Furth, William M. Lee, David E. Kleiner, Anna S. Lok, Klaus H. Kaestner, Kyong-Mi Chang
Published 2021-04-01